Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

M. Patricia Hidalgo; Carlos A. Celis; Maria Ximena Rojas-Reyes; Rodolfo J. Dennis

doi:10.1002/14651858.CD012100

Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

M. Patricia Hidalgo, Carlos A. Celis, Maria Ximena Rojas-Reyes, Rodolfo J. Dennis

Research output: Contribution to journal › Review article › peer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.

Original language	English (US)
Article number	CD012100
Journal	Cochrane Database of Systematic Reviews
Volume	2016
Issue number	2
DOIs	https://doi.org/10.1002/14651858.CD012100
State	Published - Feb 29 2016
Externally published	Yes

All Science Journal Classification (ASJC) codes

Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/14651858.CD012100

Cite this

@article{7f84ebebd97c4a9d81a64814eccf8ba9,

title = "Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.",

author = "{Patricia Hidalgo}, M. and Celis, {Carlos A.} and Rojas-Reyes, {Maria Ximena} and Dennis, {Rodolfo J.}",

note = "Publisher Copyright: {\textcopyright} 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2016",

month = feb,

day = "29",

doi = "10.1002/14651858.CD012100",

language = "English (US)",

volume = "2016",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "2",

}

Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD). / Patricia Hidalgo, M.; Celis, Carlos A.; Rojas-Reyes, Maria Ximena et al.
In: Cochrane Database of Systematic Reviews, Vol. 2016, No. 2, CD012100, 29.02.2016.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

AU - Patricia Hidalgo, M.

AU - Celis, Carlos A.

AU - Rojas-Reyes, Maria Ximena

AU - Dennis, Rodolfo J.

PY - 2016/2/29

Y1 - 2016/2/29

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.

UR - http://www.scopus.com/inward/record.url?scp=84961960801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961960801&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012100

DO - 10.1002/14651858.CD012100

M3 - Review article

AN - SCOPUS:84961960801

SN - 1465-1858

VL - 2016

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 2

M1 - CD012100

ER -

Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this